Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,401 to 1,420 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of Nusinersen in a late onset spinal muscular atrophy patient for 14 months: A case report. | Medicine (Baltimore) | 2021 | 33429824 | PubTator, text mining | PubMed |
| Safety Monitoring of Gene Therapy for Spinal Muscular Atrophy with Onasemnogene Abeparvovec -A Single Centre Experience. | J Neuromuscul Dis | 2021 | 33427694 | PubTator, text mining | PubMed |
| Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study). | Neurol Ther | 2021 | 33420962 | PubTator, text mining | PubMed |
| Comprehensive characterisation of intronic mis-splicing mutations in human cancers. | Oncogene | 2021 | 33420369 | PubTator, text mining | PubMed |
| Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR. | Neurogenetics | 2021 | 33415588 | PubTator, text mining | PubMed |
| Genetic analysis of ALS cases in the isolated island population of Malta. | Eur J Hum Genet | 2021 | 33414559 | PubTator, text mining | PubMed |
| Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes. | Biochim Biophys Acta Mol Basis Dis | 2021 | 33412266 | PubTator, text mining | PubMed |
| The Effect of SMN Gene Dosage on ALS Risk and Disease Severity. | Ann Neurol | 2021 | 33389754 | PubTator, text mining | PubMed |
| Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study. | Ann Clin Transl Neurol | 2021 | 33369268 | PubTator, text mining | PubMed |
| GeneBreaker: Variant simulation to improve the diagnosis of Mendelian rare genetic diseases. | Hum Mutat | 2021 | 33368787 | PubTator, text mining | PubMed |
| The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration. | Nucleic Acids Res | 2021 | 33367834 | PubTator, text mining | PubMed |
| Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19. | Inform Med Unlocked | 2021 | 33363251 | PubTator, text mining | PubMed |
| Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics. | Mol Ther | 2021 | 33359792 | PubTator, text mining | PubMed |
| Frameworks for targeting RNA with small molecules. | J Biol Chem | 2021 | 33334887 | PubTator, text mining | PubMed |
| A rapid molecular diagnostic method for spinal muscular atrophy. | J Neurogenet | 2021 | 33332175 | PubTator, text mining | PubMed |
| Current Clinical Applications of In Vivo Gene Therapy with AAVs. | Mol Ther | 2021 | 33309881 | PubTator, text mining | PubMed |
| Children and young adults with spinal muscular atrophy treated with nusinersen. | Eur J Paediatr Neurol | 2021 | 33307321 | PubTator, text mining | PubMed |
| Identification of SRSF10 as a regulator of SMN2 ISS-N1. | Hum Mutat | 2021 | 33300159 | PubTator, text mining | PubMed |
| MiR-CLIP reveals iso-miR selective regulation in the miR-124 targetome. | Nucleic Acids Res | 2021 | 33300035 | PubTator, text mining | PubMed |
| Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy. | Life Sci Alliance | 2021 | 33234679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=71